Medifast: Significant Undervaluation Even As Struggles Persist (NYSE:MED) | Old North State Wealth News
Connect with us

Investing

Medifast: Significant Undervaluation Even As Struggles Persist (NYSE:MED)

Published

on

Tony Anderson/DigitalVision via Getty Images

Investment thesis

As I suggested in my initial cautious thesis about Medifast (NYSE:MED), the company faced tough times over the last seven months. The emergence of drug-weight loss weighs on Medifast’s business, and its

Read the full article here

Trending

Copyright © 2022 ONSWM News. Content posted on the Old North State Wealth News page was developed and produced by a third party news aggregation service. Old North State Wealth Management is not affiliated with the news aggregation service. The information presented is believed to be current. It should not be viewed as personalized investment advice. All expressions of opinion reflect the judgment of the authors on the date the articles were published. The information presented is not an offer to buy or sell, or a solicitation of any offer to buy or sell, any of the securities discussed.